Endocrine Society's Bone Health Toolkit and Osteoporosis Guidelines App

About the Endocrine Society Osteoporosis Web App

In partnership with Guideline Central, Endocrine Society will create an educational package to improve knowledge and competencies for assessment, management, and treatment, especially with new therapies, for postmenopausal osteoporosis, and how to optimally use these guidelines in clinical practice. In addition, these guidelines aim to provide increased knowledge to endocrinologists and allied providers managing patients with postmenopausal osteoporosis, in an engaging manner. These guidelines also seek to provide knowledge to clinicians who do not treat high-risk patients on a regular basis but will nonetheless benefit from insights gained because of this digital toolkit on emerging therapies. Additionally, these guidelines will take steps towards improving outcomes for patients who suffer from postmenopausal osteoporosis. The distribution of this educational resource is supported by Amgen. It is intended for reference use only and healthcare providers must make clinical judgments based on their independent assessment of each patient. Amgen was not involved in the development of the publication or the underlying guidelines on which this publication is based.